TrialJournal of the National Cancer Institute2014

Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases.

Siow Ming Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.